0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tissue Heart Valves Device Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-21Z12765
Home | Market Reports | Health| Medical Devices & Equipment
Global Tissue Heart Valves Device Market Research Report 2022
BUY CHAPTERS

Global Tissue Heart Valves Device Market Research Report 2025

Code: QYRE-Auto-21Z12765
Report
March 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tissue Heart Valves Device Market Size

The global market for Tissue Heart Valves Device was valued at US$ 15740 million in the year 2024 and is projected to reach a revised size of US$ 32750 million by 2031, growing at a CAGR of 11.2% during the forecast period.

Tissue Heart Valves Device Market

Tissue Heart Valves Device Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tissue Heart Valves Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Heart Valves Device.
The Tissue Heart Valves Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tissue Heart Valves Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue Heart Valves Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tissue Heart Valves Device Market Report

Report Metric Details
Report Name Tissue Heart Valves Device Market
Accounted market size in year US$ 15740 million
Forecasted market size in 2031 US$ 32750 million
CAGR 11.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific Corporation, CryoLife, Medtronic, Edward Lifesciences Corporation, Sorin Group, On-X Life Technologies, Inc, JenaValve Technology Inc, TTK Healthcare Limited, Comed BV, Meril Life Sciences, Beijing Balance Medical Technology Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tissue Heart Valves Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tissue Heart Valves Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Tissue Heart Valves Device Market growing?

Ans: The Tissue Heart Valves Device Market witnessing a CAGR of 11.2% during the forecast period 2025-2031.

What is the Tissue Heart Valves Device Market size in 2031?

Ans: The Tissue Heart Valves Device Market size in 2031 will be US$ 32750 million.

Who are the main players in the Tissue Heart Valves Device Market report?

Ans: The main players in the Tissue Heart Valves Device Market are Abbott, Boston Scientific Corporation, CryoLife, Medtronic, Edward Lifesciences Corporation, Sorin Group, On-X Life Technologies, Inc, JenaValve Technology Inc, TTK Healthcare Limited, Comed BV, Meril Life Sciences, Beijing Balance Medical Technology Co., Ltd

What are the Application segmentation covered in the Tissue Heart Valves Device Market report?

Ans: The Applications covered in the Tissue Heart Valves Device Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Tissue Heart Valves Device Market report?

Ans: The Types covered in the Tissue Heart Valves Device Market report are Aortic Valve, Mitral Valve, Pulmonary Valve, Tricuspid Valve

Recommended Reports

Heart Valve Devices

Cardiac Devices & Surgery

Medical Materials & Adjacent

1 Tissue Heart Valves Device Market Overview
1.1 Product Definition
1.2 Tissue Heart Valves Device by Type
1.2.1 Global Tissue Heart Valves Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Aortic Valve
1.2.3 Mitral Valve
1.2.4 Pulmonary Valve
1.2.5 Tricuspid Valve
1.3 Tissue Heart Valves Device by Application
1.3.1 Global Tissue Heart Valves Device Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Tissue Heart Valves Device Market Size Estimates and Forecasts
1.4.1 Global Tissue Heart Valves Device Revenue 2020-2031
1.4.2 Global Tissue Heart Valves Device Sales 2020-2031
1.4.3 Global Tissue Heart Valves Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tissue Heart Valves Device Market Competition by Manufacturers
2.1 Global Tissue Heart Valves Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tissue Heart Valves Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tissue Heart Valves Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tissue Heart Valves Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tissue Heart Valves Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tissue Heart Valves Device, Product Type & Application
2.7 Global Key Manufacturers of Tissue Heart Valves Device, Date of Enter into This Industry
2.8 Global Tissue Heart Valves Device Market Competitive Situation and Trends
2.8.1 Global Tissue Heart Valves Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tissue Heart Valves Device Players Market Share by Revenue
2.8.3 Global Tissue Heart Valves Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tissue Heart Valves Device Market Scenario by Region
3.1 Global Tissue Heart Valves Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tissue Heart Valves Device Sales by Region: 2020-2031
3.2.1 Global Tissue Heart Valves Device Sales by Region: 2020-2025
3.2.2 Global Tissue Heart Valves Device Sales by Region: 2026-2031
3.3 Global Tissue Heart Valves Device Revenue by Region: 2020-2031
3.3.1 Global Tissue Heart Valves Device Revenue by Region: 2020-2025
3.3.2 Global Tissue Heart Valves Device Revenue by Region: 2026-2031
3.4 North America Tissue Heart Valves Device Market Facts & Figures by Country
3.4.1 North America Tissue Heart Valves Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tissue Heart Valves Device Sales by Country (2020-2031)
3.4.3 North America Tissue Heart Valves Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tissue Heart Valves Device Market Facts & Figures by Country
3.5.1 Europe Tissue Heart Valves Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tissue Heart Valves Device Sales by Country (2020-2031)
3.5.3 Europe Tissue Heart Valves Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tissue Heart Valves Device Market Facts & Figures by Region
3.6.1 Asia Pacific Tissue Heart Valves Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tissue Heart Valves Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Tissue Heart Valves Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tissue Heart Valves Device Market Facts & Figures by Country
3.7.1 Latin America Tissue Heart Valves Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tissue Heart Valves Device Sales by Country (2020-2031)
3.7.3 Latin America Tissue Heart Valves Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tissue Heart Valves Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Tissue Heart Valves Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tissue Heart Valves Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tissue Heart Valves Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tissue Heart Valves Device Sales by Type (2020-2031)
4.1.1 Global Tissue Heart Valves Device Sales by Type (2020-2025)
4.1.2 Global Tissue Heart Valves Device Sales by Type (2026-2031)
4.1.3 Global Tissue Heart Valves Device Sales Market Share by Type (2020-2031)
4.2 Global Tissue Heart Valves Device Revenue by Type (2020-2031)
4.2.1 Global Tissue Heart Valves Device Revenue by Type (2020-2025)
4.2.2 Global Tissue Heart Valves Device Revenue by Type (2026-2031)
4.2.3 Global Tissue Heart Valves Device Revenue Market Share by Type (2020-2031)
4.3 Global Tissue Heart Valves Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tissue Heart Valves Device Sales by Application (2020-2031)
5.1.1 Global Tissue Heart Valves Device Sales by Application (2020-2025)
5.1.2 Global Tissue Heart Valves Device Sales by Application (2026-2031)
5.1.3 Global Tissue Heart Valves Device Sales Market Share by Application (2020-2031)
5.2 Global Tissue Heart Valves Device Revenue by Application (2020-2031)
5.2.1 Global Tissue Heart Valves Device Revenue by Application (2020-2025)
5.2.2 Global Tissue Heart Valves Device Revenue by Application (2026-2031)
5.2.3 Global Tissue Heart Valves Device Revenue Market Share by Application (2020-2031)
5.3 Global Tissue Heart Valves Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Tissue Heart Valves Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Company Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Corporation Tissue Heart Valves Device Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 CryoLife
6.3.1 CryoLife Company Information
6.3.2 CryoLife Description and Business Overview
6.3.3 CryoLife Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CryoLife Tissue Heart Valves Device Product Portfolio
6.3.5 CryoLife Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Company Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medtronic Tissue Heart Valves Device Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Edward Lifesciences Corporation
6.5.1 Edward Lifesciences Corporation Company Information
6.5.2 Edward Lifesciences Corporation Description and Business Overview
6.5.3 Edward Lifesciences Corporation Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Edward Lifesciences Corporation Tissue Heart Valves Device Product Portfolio
6.5.5 Edward Lifesciences Corporation Recent Developments/Updates
6.6 Sorin Group
6.6.1 Sorin Group Company Information
6.6.2 Sorin Group Description and Business Overview
6.6.3 Sorin Group Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sorin Group Tissue Heart Valves Device Product Portfolio
6.6.5 Sorin Group Recent Developments/Updates
6.7 On-X Life Technologies, Inc
6.7.1 On-X Life Technologies, Inc Company Information
6.7.2 On-X Life Technologies, Inc Description and Business Overview
6.7.3 On-X Life Technologies, Inc Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 On-X Life Technologies, Inc Tissue Heart Valves Device Product Portfolio
6.7.5 On-X Life Technologies, Inc Recent Developments/Updates
6.8 JenaValve Technology Inc
6.8.1 JenaValve Technology Inc Company Information
6.8.2 JenaValve Technology Inc Description and Business Overview
6.8.3 JenaValve Technology Inc Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 JenaValve Technology Inc Tissue Heart Valves Device Product Portfolio
6.8.5 JenaValve Technology Inc Recent Developments/Updates
6.9 TTK Healthcare Limited
6.9.1 TTK Healthcare Limited Company Information
6.9.2 TTK Healthcare Limited Description and Business Overview
6.9.3 TTK Healthcare Limited Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TTK Healthcare Limited Tissue Heart Valves Device Product Portfolio
6.9.5 TTK Healthcare Limited Recent Developments/Updates
6.10 Comed BV
6.10.1 Comed BV Company Information
6.10.2 Comed BV Description and Business Overview
6.10.3 Comed BV Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Comed BV Tissue Heart Valves Device Product Portfolio
6.10.5 Comed BV Recent Developments/Updates
6.11 Meril Life Sciences
6.11.1 Meril Life Sciences Company Information
6.11.2 Meril Life Sciences Description and Business Overview
6.11.3 Meril Life Sciences Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Meril Life Sciences Tissue Heart Valves Device Product Portfolio
6.11.5 Meril Life Sciences Recent Developments/Updates
6.12 Beijing Balance Medical Technology Co., Ltd
6.12.1 Beijing Balance Medical Technology Co., Ltd Company Information
6.12.2 Beijing Balance Medical Technology Co., Ltd Description and Business Overview
6.12.3 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Product Portfolio
6.12.5 Beijing Balance Medical Technology Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tissue Heart Valves Device Industry Chain Analysis
7.2 Tissue Heart Valves Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tissue Heart Valves Device Production Mode & Process Analysis
7.4 Tissue Heart Valves Device Sales and Marketing
7.4.1 Tissue Heart Valves Device Sales Channels
7.4.2 Tissue Heart Valves Device Distributors
7.5 Tissue Heart Valves Device Customer Analysis
8 Tissue Heart Valves Device Market Dynamics
8.1 Tissue Heart Valves Device Industry Trends
8.2 Tissue Heart Valves Device Market Drivers
8.3 Tissue Heart Valves Device Market Challenges
8.4 Tissue Heart Valves Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Tissue Heart Valves Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tissue Heart Valves Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tissue Heart Valves Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tissue Heart Valves Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tissue Heart Valves Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tissue Heart Valves Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tissue Heart Valves Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tissue Heart Valves Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tissue Heart Valves Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tissue Heart Valves Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tissue Heart Valves Device, Product Type & Application
 Table 12. Global Key Manufacturers of Tissue Heart Valves Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tissue Heart Valves Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue Heart Valves Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tissue Heart Valves Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tissue Heart Valves Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tissue Heart Valves Device Sales Market Share by Region (2020-2025)
 Table 19. Global Tissue Heart Valves Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tissue Heart Valves Device Sales Market Share by Region (2026-2031)
 Table 21. Global Tissue Heart Valves Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tissue Heart Valves Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Tissue Heart Valves Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tissue Heart Valves Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Tissue Heart Valves Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tissue Heart Valves Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tissue Heart Valves Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tissue Heart Valves Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tissue Heart Valves Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tissue Heart Valves Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tissue Heart Valves Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tissue Heart Valves Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tissue Heart Valves Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tissue Heart Valves Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tissue Heart Valves Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tissue Heart Valves Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tissue Heart Valves Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tissue Heart Valves Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tissue Heart Valves Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tissue Heart Valves Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tissue Heart Valves Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tissue Heart Valves Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tissue Heart Valves Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tissue Heart Valves Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tissue Heart Valves Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tissue Heart Valves Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tissue Heart Valves Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tissue Heart Valves Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tissue Heart Valves Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tissue Heart Valves Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Tissue Heart Valves Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Tissue Heart Valves Device Sales Market Share by Type (2020-2025)
 Table 53. Global Tissue Heart Valves Device Sales Market Share by Type (2026-2031)
 Table 54. Global Tissue Heart Valves Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tissue Heart Valves Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tissue Heart Valves Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Tissue Heart Valves Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Tissue Heart Valves Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tissue Heart Valves Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tissue Heart Valves Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Tissue Heart Valves Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Tissue Heart Valves Device Sales Market Share by Application (2020-2025)
 Table 63. Global Tissue Heart Valves Device Sales Market Share by Application (2026-2031)
 Table 64. Global Tissue Heart Valves Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tissue Heart Valves Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tissue Heart Valves Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Tissue Heart Valves Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Tissue Heart Valves Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tissue Heart Valves Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Tissue Heart Valves Device Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Boston Scientific Corporation Company Information
 Table 76. Boston Scientific Corporation Description and Business Overview
 Table 77. Boston Scientific Corporation Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Corporation Tissue Heart Valves Device Product
 Table 79. Boston Scientific Corporation Recent Developments/Updates
 Table 80. CryoLife Company Information
 Table 81. CryoLife Description and Business Overview
 Table 82. CryoLife Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. CryoLife Tissue Heart Valves Device Product
 Table 84. CryoLife Recent Developments/Updates
 Table 85. Medtronic Company Information
 Table 86. Medtronic Description and Business Overview
 Table 87. Medtronic Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Medtronic Tissue Heart Valves Device Product
 Table 89. Medtronic Recent Developments/Updates
 Table 90. Edward Lifesciences Corporation Company Information
 Table 91. Edward Lifesciences Corporation Description and Business Overview
 Table 92. Edward Lifesciences Corporation Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Edward Lifesciences Corporation Tissue Heart Valves Device Product
 Table 94. Edward Lifesciences Corporation Recent Developments/Updates
 Table 95. Sorin Group Company Information
 Table 96. Sorin Group Description and Business Overview
 Table 97. Sorin Group Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sorin Group Tissue Heart Valves Device Product
 Table 99. Sorin Group Recent Developments/Updates
 Table 100. On-X Life Technologies, Inc Company Information
 Table 101. On-X Life Technologies, Inc Description and Business Overview
 Table 102. On-X Life Technologies, Inc Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. On-X Life Technologies, Inc Tissue Heart Valves Device Product
 Table 104. On-X Life Technologies, Inc Recent Developments/Updates
 Table 105. JenaValve Technology Inc Company Information
 Table 106. JenaValve Technology Inc Description and Business Overview
 Table 107. JenaValve Technology Inc Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. JenaValve Technology Inc Tissue Heart Valves Device Product
 Table 109. JenaValve Technology Inc Recent Developments/Updates
 Table 110. TTK Healthcare Limited Company Information
 Table 111. TTK Healthcare Limited Description and Business Overview
 Table 112. TTK Healthcare Limited Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. TTK Healthcare Limited Tissue Heart Valves Device Product
 Table 114. TTK Healthcare Limited Recent Developments/Updates
 Table 115. Comed BV Company Information
 Table 116. Comed BV Description and Business Overview
 Table 117. Comed BV Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Comed BV Tissue Heart Valves Device Product
 Table 119. Comed BV Recent Developments/Updates
 Table 120. Meril Life Sciences Company Information
 Table 121. Meril Life Sciences Description and Business Overview
 Table 122. Meril Life Sciences Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Meril Life Sciences Tissue Heart Valves Device Product
 Table 124. Meril Life Sciences Recent Developments/Updates
 Table 125. Beijing Balance Medical Technology Co., Ltd Company Information
 Table 126. Beijing Balance Medical Technology Co., Ltd Description and Business Overview
 Table 127. Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Product
 Table 129. Beijing Balance Medical Technology Co., Ltd Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Tissue Heart Valves Device Distributors List
 Table 133. Tissue Heart Valves Device Customers List
 Table 134. Tissue Heart Valves Device Market Trends
 Table 135. Tissue Heart Valves Device Market Drivers
 Table 136. Tissue Heart Valves Device Market Challenges
 Table 137. Tissue Heart Valves Device Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tissue Heart Valves Device
 Figure 2. Global Tissue Heart Valves Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tissue Heart Valves Device Market Share by Type: 2024 & 2031
 Figure 4. Aortic Valve Product Picture
 Figure 5. Mitral Valve Product Picture
 Figure 6. Pulmonary Valve Product Picture
 Figure 7. Tricuspid Valve Product Picture
 Figure 8. Global Tissue Heart Valves Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Tissue Heart Valves Device Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Ambulatory Surgical Centers
 Figure 13. Global Tissue Heart Valves Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Tissue Heart Valves Device Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Tissue Heart Valves Device Sales (2020-2031) & (K Units)
 Figure 16. Global Tissue Heart Valves Device Average Price (US$/Unit) & (2020-2031)
 Figure 17. Tissue Heart Valves Device Report Years Considered
 Figure 18. Tissue Heart Valves Device Sales Share by Manufacturers in 2024
 Figure 19. Global Tissue Heart Valves Device Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Tissue Heart Valves Device Players: Market Share by Revenue in Tissue Heart Valves Device in 2024
 Figure 21. Tissue Heart Valves Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Tissue Heart Valves Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Tissue Heart Valves Device Sales Market Share by Country (2020-2031)
 Figure 24. North America Tissue Heart Valves Device Revenue Market Share by Country (2020-2031)
 Figure 25. United States Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Tissue Heart Valves Device Sales Market Share by Country (2020-2031)
 Figure 28. Europe Tissue Heart Valves Device Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Tissue Heart Valves Device Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Tissue Heart Valves Device Revenue Market Share by Region (2020-2031)
 Figure 36. China Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Tissue Heart Valves Device Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Tissue Heart Valves Device Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Tissue Heart Valves Device Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Tissue Heart Valves Device Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Tissue Heart Valves Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Tissue Heart Valves Device by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Tissue Heart Valves Device by Type (2020-2031)
 Figure 55. Global Tissue Heart Valves Device Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Tissue Heart Valves Device by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Tissue Heart Valves Device by Application (2020-2031)
 Figure 58. Global Tissue Heart Valves Device Price (US$/Unit) by Application (2020-2031)
 Figure 59. Tissue Heart Valves Device Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart